Imperial College London
Alternate

Professor Amin Hajitou

Faculty of Medicine, Department of Brain Sciences

Professor of Targeted Therapeutics
 
 
 
//

Contact

 

+44 (0)20 7594 6546a.hajitou Website

 
 
//

Location

 

Burlington DanesHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Pranjol:2015:10.3390/v7010268,
author = {Pranjol, MZI and Hajitou, A},
doi = {10.3390/v7010268},
journal = {VIRUSES-BASEL},
pages = {268--284},
title = {Bacteriophage-Derived Vectors for Targeted Cancer Gene Therapy},
url = {http://dx.doi.org/10.3390/v7010268},
volume = {7},
year = {2015}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Cancer  gene  therapy  expanded  and  reached its  pinnaclein  research  in  the last  decade.  Both  viral  and  non-viral  vectors  have  entered  clinical  trials,and  significant successes have beenachieved. However, a systemic administration of a vector,illustrating safe, efficient,and targeted gene delivery to solid tumors has proven to bea major challenge. In  this  review,  we  summarize the current  progress  and  challenges  in the targeted  gene therapyof cancer. Moreover, we highlight the recent developments of bacteriophage-derived vectors  and  their  contributions  in  targeting cancer  with therapeutic  genes  following systemic administration.
AU  - Pranjol,MZI
AU  - Hajitou,A
DO  - 10.3390/v7010268
EP  - 284
PY  - 2015///
SN  - 1999-4915
SP  - 268
TI  - Bacteriophage-Derived Vectors for Targeted Cancer Gene Therapy
T2  - VIRUSES-BASEL
UR  - http://dx.doi.org/10.3390/v7010268
UR  - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000348401600013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR  - http://hdl.handle.net/10044/1/59700
VL  - 7
ER  -
Download